Content related to When Good Immune Cells Turn Bad
A Higher Resolution Image of Human Lung Development
October 17, 2019
The invention of interactive map applications has revolutionized wayfinding, providing an unprecedented level of information far beyond what printed road maps can offer. Researchers at Children’s
Why Are Some Retinoblastoma Tumors More Aggressive?
September 23, 2022
A new study finds a reason, paving the way for the development of new, more effective treatments.
What Makes a Cell Turn Cancerous?
March 14, 2019
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age and accounts for approximately 4% of childhood cancers. If not diagnosed early, retinoblastoma may result
Theranostics: Combining Cancer Therapeutics and Diagnostics
October 28, 2015
Researchers at The Saban Research Institute, Cedars-Sinai Medical Center and Caltech have unveiled a novel nanoparticle complex that induces tumor cell death while enhancing contrast in MRI images.
Can a Tiny Fish Transform Treatment for Childhood Cancers?
October 13, 2021
A physician-scientist is harnessing the power of zebrafish—and a new, state-of-the-art facility—to develop innovative treatments for solid tumors in children.
5 THINGS TO KNOW ABOUT COVID-19 RESEARCH
October 13, 2021
The pandemic stopped the world in its tracks, forcing many industries to shut down. Research was affected, with labs closed and investigators asked to work remotely. But while many projects were
Rac1 Protein Critical for Lung Development
October 27, 2016
A study by researchers from The Saban Research Institute of Children’s Hospital Los Angeles reveals a promising therapeutic target for improving lung function in infants. Their study, now published
Clinical Trial Results: Patients with Leukemia Show High Remission Rates after Immunotherapy
October 16, 2014
Researchers at Children's Hospital Los Angeles have published results of this study in Lancet.
Stay Up to Date
Sign up to receive our monthly newsletter, latest news, events and stories delivered right to your inbox.